These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11366945)

  • 1. Women, HIV & viral load.
    Denison R
    WORLD; 1999 Apr; (No 96):4-5. PubMed ID: 11366945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender difference in viral load.
    Proj Inf Perspect; 1999 Apr; (27):18-9. PubMed ID: 11366734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case of the undetectable viral load.
    Jenny-Avital ER
    AIDS Clin Care; 1999 Mar; 11(3):20-1. PubMed ID: 11366207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender difference in HIV-1 RNA viral loads.
    Donnelly CA; Bartley LM; Ghani AC; Le Fevre AM; Kwong GP; Cowling BJ; van Sighem AI; de Wolf F; Rode RA; Anderson RM
    HIV Med; 2005 May; 6(3):170-8. PubMed ID: 15876283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns, predictors, and consequences of initial regimen type among HIV-infected women receiving highly active antiretroviral therapy.
    Golub ET; Benning L; Sharma A; Gandhi M; Cohen MH; Young M; Gange SJ
    Clin Infect Dis; 2008 Jan; 46(2):305-12. PubMed ID: 18171267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
    Collazos J; Asensi V; Cartón JA
    AIDS; 2007 Apr; 21(7):835-43. PubMed ID: 17415038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection.
    Chantry CJ; Byrd RS; Englund JA; Baker CJ; McKinney RE;
    Pediatr Infect Dis J; 2003 Dec; 22(12):1033-9. PubMed ID: 14688560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
    Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
    Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F; Uberti Foppa C; Boeri E; Racca S; Gallotta G; Grasso MA; Calori G; Lazzarin A; Clementi M
    J Biol Regul Homeost Agents; 2003; 17(2):191-4. PubMed ID: 14518722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines shed light on identifying failed regimens.
    AIDS Alert; 1997 Aug; 12(8):87-8. PubMed ID: 11364472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY; Diallo K; Adje-Toure C; Chorba T; Nkengasong JN
    J Clin Virol; 2009 May; 45(1):72-5. PubMed ID: 19375979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rift over viral load data and clinical guidelines.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1997 Oct; 3(10):36-7. PubMed ID: 11364745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.
    Clevenbergh P; Boulmé R; Kirstetter M; Dellamonica P
    HIV Med; 2004 Jul; 5(4):284-8. PubMed ID: 15236618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus immunocapture provides evidence of CD8 lymphocyte-derived HIV-1 in vivo.
    Hughes GJ; Willey SJ; Cochrane A; Leen C; Bell JE; Simmonds P
    AIDS; 2007 Jul; 21(12):1507-13. PubMed ID: 17630544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.